Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial (Q60716134)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial |
article |
Statements
Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial (English)
Mogens Groenvold
Henning T Mouridsen
16 March 2006